Advertisement Information
| Advertisement No. : |
TMC/AD/17/2026
|
| Advertisement Name : |
WALK-IN INTERVIEW
03/02/2026
ON
20.02.2026
Reporting Time: 10:00 A.M. TO 11:00 A.M.
Required ‘Clinical Research Coordinator’ under “Phase II study of
Bendamustine and fixed dose Nivolumab in Children with relapsed or Refractory
Hodgkin Lymphona” (A/c. No. 6975) & “A Pivotal Phase 2 trial of Antibody
Naxitamab (hu3F8) and granulocyte-Macrophage Colony Stimulating Factor (GM
CSF) in High-Risk Neuroblastoma Patients with Primary Refractory Disease or
Incomplete Response to salvage Treatment in Bone and/or Bone Marrow”. (A/c. No.
6847). (Initially for a period of six months)
|
| Start Date : |
03/02/2026 |
End Date : |
20/02/2026 |
| Job Type : |
Project Posts |
Location : |
TMH Mumbai |